Patient characteristics and clinical status at the time of serum collection for human IL-21 analysis
| Graft source . | Conditioning (full/reduced) . | Matching (related/unrelated) . | GVHD grade (0/1/2/3/4) . | Sample date post-treatment aGVHD history (active/none/inactive) . | Steroid refractory GVHD . |
|---|---|---|---|---|---|
| Adult | 37/14 | 26/25 | 20/14/10/5/2 | 23/35/24 | 5 |
| Cord | 44/0 | 0/44 | 16/1/17/4/6 | 13/18/13 | 0 |
| Graft source . | Conditioning (full/reduced) . | Matching (related/unrelated) . | GVHD grade (0/1/2/3/4) . | Sample date post-treatment aGVHD history (active/none/inactive) . | Steroid refractory GVHD . |
|---|---|---|---|---|---|
| Adult | 37/14 | 26/25 | 20/14/10/5/2 | 23/35/24 | 5 |
| Cord | 44/0 | 0/44 | 16/1/17/4/6 | 13/18/13 | 0 |
A total of 95 adult patients undergoing allo-HCT with cells from either adult or cord blood were used in this analysis.